Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
15 participants
OBSERVATIONAL
2010-07-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stereotactic Radiosurgery in Treating Patients With Spinal Metastases
NCT00853528
Evaluation of Spinal Metastatic Tumour for Aggressive Spinal Sugery by Dual Energy CT
NCT03631095
Spinal met_radiosurgery/SBRT Study
NCT01231061
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
NCT01890590
Proton Radiation for Chordomas and Chondrosarcomas
NCT01449149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* There are no age or gender restrictions.
* There are no life expectancy restrictions.
* Karnofsky Performance Status greater than 40.
* Negative pregnancy test or clinically assessed as not pregnant.
* Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria
* Other investigational medications or treatments will be noted, but will not preclude inclusion.
* Pregnant or nursing patients will be not be included in the study due to radiation exposure.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven Daniel Chang
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU-07092010-6499
Identifier Type: OTHER
Identifier Source: secondary_id
SPN0002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.